Associated Papers
Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.
Jin N et al.
The Journal of Clinical Investigation, 2021
Translational genomics and recent advances in oral squamous cell carcinoma.
Chai AWY et al.
Seminars in Cancer Biology, 2020
A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma.
Mazumdar T et al.
Molecular Cancer Therapeutics, 2014
The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.
Giudice FS et al.
Journal of Carcinogenesis & Mutagenesis, 2013
Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers.
Lui VW et al.
Cancer Discovery, 2013
Select a paper to view details